Wangzhi Li
Analyst-Equity at Ladenburg Thalmann & Co., Inc. (Broker)
Profile
Dr. Wangzhi Li is a Managing Director of Equity Research at Ladenburg Thalmann & Co., Inc. He covers small-to-mid cap biotech companies in oncology and other therapeutic areas.
Prior to his current role, he worked with Matt Kaplan in covering small-to-mid cap biopharma companies in oncology, endocrinology, nephrology, gastroenterology, ophthalmology, pain and drug delivery etc.
Before joining in Ladenburg, Dr. Li worked in healthcare venture capital at Easton Capital and New York City Investment Fund.
Dr. Li did his PhD research in cancer biology and epigenetics at Cold Spring Harbor Laboratory, New York and published multiple papers in Nature Communications, Epigenomics, Nature Cell Biology and Cell Stem Cell etc.
Dr. Li received his bachelor's degree in biological science from Xiamen University, China.
Wangzhi Li active positions
| Companies | Position | Start |
|---|---|---|
Ladenburg Thalmann & Co., Inc. (Broker)
 Ladenburg Thalmann & Co., Inc. (Broker) Investment Banks/BrokersFinance Ladenburg Thalmann & Co., Inc. (Broker) is the broker/dealer division of Ladenburg Thalmann & Co., Inc., ultimately held by Advisor Group Holdings, Inc. Headquartered in New York City, the firm was founded in 1876 and offers a full suite of capital markets products and services, including proprietary equity research and a fixed-income trading desk. For institutional asset management clients, the firm provides liquidity, execution, high-quality idea-generating research, and access to corporate management teams. Their institutional coverage includes relationships with over asset management companies all over the world. To corporate clients, they bring access to investor capital, broad distribution capabilities and financial markets advisory. Ladenburg Thalmann is a leader in financing growing middle-market public companies across various industry verticals, including Healthcare & Life Sciences, Yield-Oriented Securities (BDCs, REITs, MLPs), Energy, Power & Infrastructure, and Telecom, Media & Technology. | Analyst-Equity | 2013-12-31 |
Training of Wangzhi Li
| Xiamen University | Undergraduate Degree |
| Stony Brook University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Ladenburg Thalmann & Co., Inc. (Broker)
Ladenburg Thalmann & Co., Inc. (Broker) Investment Banks/BrokersFinance Ladenburg Thalmann & Co., Inc. (Broker) is the broker/dealer division of Ladenburg Thalmann & Co., Inc., ultimately held by Advisor Group Holdings, Inc. Headquartered in New York City, the firm was founded in 1876 and offers a full suite of capital markets products and services, including proprietary equity research and a fixed-income trading desk. For institutional asset management clients, the firm provides liquidity, execution, high-quality idea-generating research, and access to corporate management teams. Their institutional coverage includes relationships with over asset management companies all over the world. To corporate clients, they bring access to investor capital, broad distribution capabilities and financial markets advisory. Ladenburg Thalmann is a leader in financing growing middle-market public companies across various industry verticals, including Healthcare & Life Sciences, Yield-Oriented Securities (BDCs, REITs, MLPs), Energy, Power & Infrastructure, and Telecom, Media & Technology. | Finance |
- Stock Market
- Insiders
- Wangzhi Li
